MiNK Therapeutics(INKT) - 2024 Q1 - Earnings Call Transcript

MiNK Therapeutics, Inc. (NASDAQ:INKT) Q1 2024 Earnings Conference Call May 14, 2024 8:30 AM ET Company Participants Zack Armen - Head, Investor Relations Jennifer Buell - President and Chief Executive Officer Marc Van Dijk - Chief Scientific Officer Christine Klaskin - Principal Financial and Accounting Officer Dr. Dhan Chand - Head of Discovery at Agenus Conference Call Participants Emily Bodnar - H.C. Wainwright Jack Allen – Baird Matthew Phipps - William Blair Operator Good morning, and welcome to the Mi ...